A Prospective Study for the Early Diagnosis of Lung Cancer in Korean Females
Recruiting · NCT06181929 · Interventional (participants receive a specific treatment) · Lead sponsor: Sang-Won Um
View the official record on ClinicalTrials.gov →Interventions studied
Low dose CT
What this trial is about
This is a single-arm prospective pilot study in a single institution. The target accrual is 200 participants of Korean, female sex, never smoker status, and family history of lung cancer. The study will aim to enroll 200 participants in two years.
Who can take part
Age range
45 Years to 74 Years
Sex
Female
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Age 45-74 years old
- Korean female
- Never smoker defined as a lifetime exposure of less than 100 cigarettes
- Family history of lung cancer at first degree relatives (parents, siblings, or children)
Exclusion criteria
- Prior history of lung cancer.
- Diagnosis of any cancer within the past five years
- Participation in a cancer prevention trial.
- Present symptoms suggestive of current lung cancer, including: unexplained weight loss of over 5 kilograms within the last 12 months or unexplained hemoptysis.
- Medical or psychiatric condition precluding informed medical consent.
- History of LDCT screening, chest CT, PET or PET/CT scan within 10 years
Where it is running
1 location listed.
- Samsung Medical Center - Seoul, Seoul, South Korea